References
1. Sarris-Michopoulos P, Magarakis M. Left atrial appendage exclusion in patients with atrial fibrillation: should it become standard of care? J Card Surg.
2. Regazzoli D, Ancona F, Trevisi N, et al. Left atrial appendage: physiology, pathology, and role as a therapeutic target. Biomed Res Int. 2015;2015:205013. doi:10.1155/2015/205013
3. Tabata T, Oki T, Yamada H, et al. Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgery.Am J Cardiol. 1998;81(3):327-332. doi:10.1016/s0002-9149(97)00903-x
4. Whitlock RP, Belley-Cote EP, Paparella D, et al. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021;384(22):2081-2091. doi:10.1056/NEJMoa2101897
5. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61(2):755-759. doi:10.1016/0003-4975(95)00887-X
6. Reddy Vivek Y., Doshi Shephal K., Kar Saibal, et al. 5-Year outcomes after left atrial appendage closure. J Am Coll Cardiol. 2017;70(24):2964-2975. doi:10.1016/j.jacc.2017.10.021
7. Carnicelli AP, Hong H, Connolly SJ, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex.Circulation. Published online January 5, 2022. doi:10.1161/CIRCULATIONAHA.121.056355
8. Osmancik P, Herman D, Neuzil P, et al. 4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2022;79(1):1-14. doi:10.1016/j.jacc.2021.10.023
9. van Laar C, Verberkmoes NJ, van Es HW, et al. Thoracoscopic left atrial appendage clipping: a multicenter cohort analysis. JACC Clin Electrophysiol. 2018;4(7):893-901. doi:10.1016/j.jacep.2018.03.009
10. Branzoli S, Marini M, Guarracini F, et al. Epicardial standalone left atrial appendage clipping for prevention of ischemic stroke in patients with atrial fibrillation contraindicated for oral anticoagulation. J Cardiovasc Electrophysiol. 2020;31(8):2187-2191. doi:10.1111/jce.14599
11. Cartledge R, Suwalski G, Witkowska A, et al. Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation.Interact Cardiovasc Thorac Surg. Published online December 6, 2021. doi:10.1093/icvts/ivab334
12. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139-1151. doi:10.1056/NEJMoa0905561
13. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-891. doi:10.1056/NEJMoa1009638
14. Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981-992. doi:10.1056/NEJMoa1107039
15. Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093-2104. doi:10.1056/NEJMoa1310907
16. CHAMPION-AF clinical trial - full text view - clinicaltrials.gov. Accessed January 18, 2022. https://clinicaltrials.gov/ct2/show/NCT04394546
17. Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation. Chest. Published online 2010. doi:10.1378/chest.09-1584
18. van den Ham HA, Klungel OH, Singer DE, Leufkens HGM, van Staa TP. Comparative performance of ATRIA, CHADS2, AND CHA2DS2-VASC RISK scores predicting stroke in patients with atrial fibrillation: results from a national primary care database. J Am Coll Cardiol. 2015;66(17):1851-1859. doi:10.1016/j.jacc.2015.08.033
19. Lip GYH, Frison L, Halperin JL, Lane DA. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.Stroke. 2010;41(12):2731-2738. doi:10.1161/STROKEAHA.110.590257
20. Shen Mark J., Arora Rishi, Jalife José. Atrial myopathy. JACC: Basic to Translational Science. 2019;4(5):640-654. doi:10.1016/j.jacbts.2019.05.005
21. Rivner H, Mitrani RD, Goldberger JJ. Atrial myopathy underlying atrial fibrillation.Arrhythm Electrophysiol Rev. 2020;9(2):61-70. doi:10.15420/aer.2020.13
22. Ronsoni RM, Saffi MAL, Gonçalves MVM, Nakayama IH, Luz Leiria TL. A new vision at the interface of atrial fibrillation and stroke. Front Cardiovasc Med. 2021;8:689313. doi:10.3389/fcvm.2021.689313
23. Khurram IM, Dewire J, Mager M, et al. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm. 2013;10(12):1843-1849. doi:10.1016/j.hrthm.2013.09.065
24. Anselmino M, Scaglione M, Di Biase L, et al. Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation. Heart Rhythm. 2014;11(1):2-7. doi:10.1016/j.hrthm.2013.10.020
25. He J, Tse G, Korantzopoulos P, et al. P-Wave indices and risk of ischemic stroke: a systematic review and meta-analysis. Stroke. 2017;48(8):2066-2072. doi:10.1161/STROKEAHA.117.017293
26. Huang Z, Zheng Z, Wu B, et al. Predictive value of P wave terminal force in lead V1 for atrial fibrillation: A meta-analysis. Ann Noninvasive Electrocardiol. 2020;25(4):e12739. doi:10.1111/anec.12739
27. Hsu PC, Lee WH, Chu CY, et al. Prognostic role of left atrial strain and its combination index with transmitral E-wave velocity in patients with atrial fibrillation.Sci Rep. 2016;6:17318. doi:10.1038/srep17318
28. Leung M, van Rosendael PJ, Abou R, et al. Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry.Eur Heart J. 2018;39(16):1416-1425. doi:10.1093/eurheartj/ehx736
29. Tsao HM, Hu WC, Tsai PH, et al. The abundance of epicardial adipose tissue surrounding left atrium is associated with the occurrence of stroke in patients with atrial fibrillation. Medicine . 2016;95(14):e3260. doi:10.1097/MD.0000000000003260
30. Hijazi Z, Oldgren J, Andersson U, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012;125(13):1605-1616. doi:10.1161/CIRCULATIONAHA.111.038729
31. Berg DD, Ruff CT, Jarolim P, et al. Performance of the ABC Scores for Assessing the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48. Circulation. 2019;139(6):760-771. doi:10.1161/CIRCULATIONAHA.118.038312
32. Lee DC, Markl M, Ng J, et al. Three-dimensional left atrial blood flow characteristics in patients with atrial fibrillation assessed by 4D flow CMR. Eur Heart J Cardiovasc Imaging. 2016;17(11):1259-1268. doi:10.1093/ehjci/jev304
33. Markl M, Lee DC, Furiasse N, et al. Left atrial and left atrial appendage 4d blood flow dynamics in atrial fibrillation. Circ Cardiovasc Imaging. 2016;9(9):e004984. doi:10.1161/CIRCIMAGING.116.004984
34. Markl M, Lee DC, Ng J, Carr M, Carr J, Goldberger JJ. Left atrial 4-dimensional flow magnetic resonance imaging: stasis and velocity mapping in patients with atrial fibrillation. Invest Radiol. 2016;51(3):147-154. doi:10.1097/RLI.0000000000000219
35. Passman R. “Pill-in-Pocket” anticoagulation for atrial fibrillation: fiction, fact, or foolish? Circulation. 2021;143(23):2211-2213. doi:10.1161/CIRCULATIONAHA.121.053170